Loading...
Target Audience: Gastroenterologists, hepatologists, primary care clinicians, infectious disease specialists
Target Population: Patients who have achieved a sustained virologic response (SVR) after treatment of hepatitis C virus (HCV) infection with oral direct-acting antiviral regimens (DAAs)
With the advent of safe and highly effective DAAs, cure of HCV infection has become more frequent. On the basis of randomized and observational studies, systematic reviews, and expert opinion, the authors of this clinical practice update present key recommendations about whether, when, and how long HCV patients who have achieved SVR should receive ongoing liver care…